Cambridge Cognition Holdings Plc (LON:COG – Get Free Report)’s share price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 35.83 and traded as low as GBX 32.02. Cambridge Cognition shares last traded at GBX 32.02, with a volume of 7,248 shares traded.
Cambridge Cognition Stock Performance
The company has a market cap of £18.13 million, a P/E ratio of -8.64 and a beta of 0.80. The company has a quick ratio of 0.96, a current ratio of 0.40 and a debt-to-equity ratio of 29.16. The stock’s 50-day moving average price is GBX 34.28 and its 200 day moving average price is GBX 35.92.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Further Reading
- Five stocks we like better than Cambridge Cognition
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
